Carl Gustav Figdor

This inventor holds 15 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignees: Katholieke Universiteit Nijmegen, Stichting Katholieke Universiteit, Stichting Radboud Universitair Medisch Centrum. Active years: 1989-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carl Gustav Figdor. Retrieved from https://idiyas.com/inventor/carl-gustav-figdor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 5)

% Patents Active = 60.0

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 292(Granted Patents)

Location History:

1066 CX Amsterdam, NL (1989)
Den Bosch, NL (2006 - 2012)
's-hertogenbosch, NL (2012 - 2021)
Nijmegen, NL (2002 - 2023)

Company Filing History:

4 out of 5

Katholieke Universiteit Nijmegen

patents

4 out of 64

Stichting Katholieke Universiteit

patents

3 out of 9

Stichting Radboud Universitair Medisch Centrum

patents

4. 2 out of 41

Miltenyi Biotec B.v. Co., Kg

Klip Consultancy B.v.

patent

7. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12102688 - Immunomodulatory nanofilaments (2024-10-01),

2. 11612644 - Cell population for use in treating cancer (2023-03-28),

3. 11286352 - Process for preparation of beads for imaging (2022-03-29),

4. 11185600 - Contrast agent and its use for imaging (2021-11-30),

5. 10925944 - Cell population for use in treating cancer (2021-02-23),

6. 10350298 - Immunomodulatory protein constructs with a helical polymeric backbone (2019-07-16),

7. 8333725 - Device comprising a container system for a bodily fluid (2012-12-18),

8. 8105599 - Composition and method for modulating dendritic cell-T cell interaction (2012-01-31),

9. 8058400 - Composition and method for modulating dendritic cell-t cell interaction (2011-11-15),

10. 7691591 - Methods of identifying and isolating cells expressing DC-sign (2010-04-06),

11. 7541032 - [object Object] (2009-06-02),

12. 7285642 - Composition and method for modulating dendritic cell-T cell interaction (2007-10-23),

13. 7148329 - Composition and method for modulating dendritic cell-t cell interaction (2006-12-12),

14. 6500919 - Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma (2002-12-31),

15. 4850952 - Method and device for the separation and isolation of blood or bone (1989-07-25),

Title: The Innovative Journey of Carl Gustav Figdor

Introduction: Carl Gustav Figdor, a distinguished inventor hailing from Den Bosch, NL, has made significant contributions to the field of innovations and patents with his groundbreaking work.

Latest Patents: Carl Gustav Figdor's latest patents showcase his commitment to pushing the boundaries of technology and science, with a focus on improving healthcare and biotechnology.

Career Highlights: Throughout his illustrious career, Carl Gustav Figdor has been at the forefront of cutting-edge research and development, leading to the creation of revolutionary inventions that have transformed industries.

Collaborations: Carl Gustav Figdor has collaborated with leading experts in the field, including renowned scientists, engineers, and researchers, to bring his innovative ideas to life and make a lasting impact on society.

Conclusion: In conclusion, Carl Gustav Figdor's passion for innovation and relentless pursuit of excellence have solidified his position as a trailblazing inventor, inspiring the next generation of visionaries to continue pushing the boundaries of what is possible.

Profile summary based on public USPTO records.